Intra-Cellular Therapies
ITCI
#1825
Rank
C$12.67 B
Marketcap
$119.60
Share price
0.28%
Change (1 day)
46.97%
Change (1 year)

Intra-Cellular Therapies (ITCI) - Cash on Hand

Cash on Hand as of September 2024 : C$1.40 Billion

According to Intra-Cellular Therapies's latest financial reports the company has C$1.40 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Intra-Cellular Therapies - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.66 B-17.77%
2022-12-31C$0.80 B52.84%
2021-12-31C$0.52 B-37.31%
2020-12-31C$0.83 B186.53%
2019-12-31C$0.29 B-38.2%
2018-12-31C$0.47 B-18.91%
2017-12-31C$0.58 B13.1%
2016-12-31C$0.51 B-21.7%
2015-12-31C$0.65 B338.15%
2014-12-31C$0.15 B280.44%
2013-12-31C$39.54 M107.72%
2013-03-31C$0 M
2012-12-31C$19.03 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$61.88 M-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
C$39.58 M-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.75 B-46.06%๐Ÿ‡บ๐Ÿ‡ธ USA